iShares Nasdaq Biotechnology ETF (IBB)

Add to Watchlists
Create an Alert
320.74 +0.63  +0.20% NASDAQ Jun 23, 20:00 Delayed 2m USD
View Full Chart
IBB Price Chart

IBB Key Stats

IBB Performance

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 10.24% 7.50% 20
3M 11.10% 10.30% 27
6M 17.90% 19.13% 61
1Y 22.58% 19.30% 28
3Y 8.42% 10.02% 74
5Y 20.21% 18.23% 27
As of June 23, 2017
Returns for periods of 1 year and above are annualized.

IBB Asset Allocation

Type % Net % Long % Short
Cash 0.09% 0.09% 0.00
Stock 99.91% 99.91% 0.00
Bond 0.00 0.00 0.00
Convertible 0.00 0.00 0.00
Preferred 0.00 0.00 0.00
Other 0.00 0.00 0.00
As of June 22, 2017

IBB Region Exposure

Americas 98.34%
North America 98.34%
Latin America 0.00
Greater Europe 1.21%
United Kingdom 0.48%
Europe Developed 0.67%
Europe Emerging 0.00
Africa/Middle East 0.05%
Greater Asia 0.45%
Japan 0.00
Australasia 0.00
Asia Developed 0.00
Asia Emerging 0.45%
Market Classification
% Developed Markets 99.55%
% Emerging Markets 0.45%
As of June 22, 2017
Region breakdown data is calculated by using the long position holdings of the portfolio.

IBB Stock Sector Exposure

Basic Materials 0.00
Communication Services 0.00
Consumer Cyclical 0.00
Consumer Defensive 0.00
Energy 0.00
Financial Services 0.00
Healthcare 99.92%
Industrials 0.00
Real Estate 0.00
Technology 0.08%
Utilities 0.00
As of June 22, 2017

IBB Stock Market Capitalization

Giant 16.37%
Large 42.24%
Medium 17.56%
Small 13.97%
Micro 9.87%
As of June 22, 2017

IBB Stock Style Exposure

Large Cap Value 10.32%
Large Cap Blend 16.34%
Large Cap Growth 33.67%
Mid Cap Value 3.17%
Mid Cap Blend 0.00
Mid Cap Growth 14.54%
Small Cap Value 1.25%
Small Cap Blend 2.40%
Small Cap Growth 18.31%
As of June 22, 2017
View More Holdings

IBB Top 10 Holdings

Symbol Name % Weight Price % Chg
CELG Celgene Corp 8.33% 134.31 +0.47%
BIIB Biogen Inc 8.07% 280.32 -0.09%
AMGN Amgen Inc 7.98% 172.50 -0.76%
REGN Regeneron Pharmaceuticals Inc 7.85% 517.33 -1.75%
GILD Gilead Sciences Inc 7.74% 70.52 +0.06%
ALXN Alexion Pharmaceuticals Inc 4.16% 126.07 -0.13%
VRTX Vertex Pharmaceuticals Inc 3.91% 133.50 -1.50%
INCY Incyte Corp 3.74% 136.28 +0.48%
ILMN Illumina Inc 3.68% 185.28 +1.25%
MYL Mylan NV 3.07% 39.03 +0.05%
As of June 22, 2017
Advertisement

IBB Ratings

Fiduciary Score Upgrade

IBB One Page Reports

IBB Basic Info

Style
Equity Style Mid Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Technology
Fund Owner Firm Name iShares
Benchmark Index
NASDAQ Biotechnology TR USD
100.0%

IBB Manager Info

Name Tenure
Alan Mason 1.13 yrs
Diane Hsiung 9.42 yrs
Greg Savage 9.42 yrs
Jennifer Hsui 4.83 yrs

IBB Net Fund Flows

1M -147.35M
3M -274.80M
6M -529.68M
YTD -515.58M
1Y 827.50M
3Y 2.004B
5Y 3.296B
10Y 3.253B
As of May 31, 2017

IBB Risk Info

Beta (5Y) 1.374
Max Drawdown (All) 62.85%
Historical Sharpe (10Y) 0.7284
Historical Sortino (All) 0.548
30-Day Rolling Volatility 19.06%
Daily Value at Risk (VaR) 1% (All) 4.87%
Monthly Value at Risk (VaR) 1% (All) 19.70%

IBB Fundamentals

Dividend Yield TTM (6-23-17) 0.20%
SEC Yield (12-31-15) 0.00%
Weighted Average PE Ratio 20.33
Weighted Average Price to Sales Ratio 5.800
Weighted Average Price to Book Ratio 4.731
Weighted Median ROE 9.70%
Weighted Median ROA -1.98%
Forecasted Dividend Yield 0.62%
Forecasted PE Ratio 18.78
Forecasted Price to Sales Ratio 4.576
Forecasted Price to Book Ratio 3.765
Number of Holdings 164
As of June 22, 2017

IBB Growth Estimates

Forecasted 5 Yr Earnings Growth 10.42%
Forecasted Book Value Growth 16.82%
Forecasted Cash Flow Growth 16.82%
Forecasted Earnings Growth 13.62%
Forecasted Revenue Growth 15.71%
As of June 22, 2017

IBB Comparables

Edit

IBB Attributes

Key Dates
Inception Date 2/5/2001
Last Annual Report Date 3/31/2017
Last Prospectus Date 8/1/2016
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

IBB Excel Add-In Codes

  • Name: =YCI("IBB","name")
  • Broad Asset Class: =YCI("IBB", "broad_asset_class")
  • Broad Category: =YCI("IBB", "broad_category_group")
  • Prospectus Objective: =YCI("IBB", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.